What is the Ketone-Glucose Ratio?
The ketone-glucose ratio, more formally known as the Glucose Ketone Index (GKI), is a calculated ratio that divides blood glucose levels by blood ketone levels to create a single numerical value for monitoring metabolic states. While the GKI has been studied primarily in metabolic therapy for brain cancer and ketogenic diet monitoring, it is NOT a standard diagnostic or monitoring tool for diabetic ketoacidosis (DKA) in clinical practice 1.
How It's Calculated
The GKI is calculated as:
- Blood Glucose (mmol/L) ÷ Blood Ketone (β-hydroxybutyrate in mmol/L) = GKI
If glucose is measured in mg/dL, convert to mmol/L first by dividing by 18.
Clinical Context and Limitations
For DKA assessment, the GKI is not recommended or mentioned in current diabetes guidelines. Instead, standard DKA diagnosis and monitoring relies on three separate parameters 2, 3:
Standard DKA Diagnostic Criteria:
- Blood glucose >250 mg/dL (though euglycemic DKA can occur, especially with SGLT2 inhibitors)
- Venous pH <7.3 (mild DKA: 7.25-7.30; moderate: 7.00-7.24; severe: <7.00)
- Serum bicarbonate <18 mEq/L (varies by severity)
- Positive ketones - specifically β-hydroxybutyrate (bOHB)
Key Monitoring Principle for DKA:
Measure β-hydroxybutyrate (bOHB) specifically in blood for both diagnosis and monitoring of DKA 2. The nitroprusside reaction methods (urine dipsticks, some blood tests) should NOT be used to monitor DKA treatment because they don't measure bOHB—the predominant ketone in DKA 2, 3.
Why Separate Measurements Matter More Than a Ratio
During DKA treatment, glucose and ketones change at different rates:
- Glucose typically falls 50-75 mg/dL per hour with insulin therapy 3
- Ketonemia takes longer to clear than hyperglycemia 3, 4
- bOHB converts to acetoacetate during successful therapy, which can falsely suggest worsening ketosis if using nitroprusside methods 3, 4
Resolution of DKA is defined by: glucose <200 mg/dL, bicarbonate ≥18 mEq/L, and venous pH >7.3 3, 4—not by any glucose-ketone ratio.
Where GKI Has Been Studied
The GKI calculator was developed for monitoring metabolic therapy in brain cancer patients using ketogenic diets, where lower GKI values correlate with therapeutic efficacy 1. This application is fundamentally different from acute DKA management.
Practical Clinical Approach
For ketosis-prone individuals (type 1 diabetes, history of DKA, or on SGLT2 inhibitors), the guideline recommendation is straightforward 2:
- Check blood or urine ketones when experiencing unexplained hyperglycemia or ketosis symptoms (abdominal pain, nausea)
- Action threshold: bOHB ≥0.8 mmol/L warrants intervention 5
- Implement sick day rules: oral hydration, additional rapid-acting insulin, frequent monitoring
- Seek medical attention if ketones continue rising or symptoms worsen
The emerging technology of continuous ketone monitoring (CKM) shows promise for early DKA detection 6, 7, but this monitors absolute ketone values, not ratios with glucose.